Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies

By sjmartinez • October 27, 2024

Liu Z, Li YR, Yang Y, Zhu Y, Yuan W, Hoffman T, Wu Y, Zhu E, Zarubova J, Shen J, Nan H, Yeh KW, Hasani-Sadrabadi MM, Zhu Y, Fang Y, Ge X, Li Z, Soto J, Hsiai T, Yang L, Li S. Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies. Nat Biomed Eng. 2024 Oct 25. doi: 10.1038/s41551-024-01272-w. Epub ahead of print. PMID: 39455719.

Tags: Cardiology/Epi, Publications, Veterans Administration

Trends and Disparities in Coronary Artery Disease and Obesity-Related Mortality in the United States From 1999-2022

Ahmed M, Javaid H, Shafiq A, Nadeem ZA, Ahsan A, Nofal A, Ahmed R, Alam M, Fudim M, Fonarow GC, Mamas MA. Trends and Disparities[...]

Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins

Razmjou AA, Kremer JM, Pappas DA, Curtis JR, Wang J, Shahbazian A, Elashoff DA, Guo R, Meriwether D, Sulaiman D, O'Connor E, Reddy ST, Charles-Schoeman[...]

Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair

Ramadoss S, Qin J, Tao B, Thomas NE, Cao E, Wu R, Sandoval DR, Piermatteo A, Grunddal KV, Ma F, Li S, Sun B, Zhou[...]